22. Nat Rev Endocrinol. 2018 Jun;14(6):329-330. doi: 10.1038/s41574-018-0021-5.Anti-VEGF therapy - a role in obesity-related breast cancer.Omene C(1), Bandera EV(2).Author information: (1)Division of Medical Oncology, Rutgers Cancer Institute of New Jersey, Rutgers University, Robert Wood Johnson Medical School, New Brunswick, NJ, USA.co273@cinj.rutgers.edu.(2)Division of Population Science, Rutgers Cancer Institute of New Jersey,Rutgers University, Robert Wood Johnson Medical School, New Brunswick, NJ, USA.DOI: 10.1038/s41574-018-0021-5 PMID: 29695750 